Skip to content

Geoff Dillon

Executive Officer at Trellis Bioscience.

Earliest Form D on file: May 2026

Filed May 15, 2026

Trellis Bioscience

Biofilm-disrupting antibodies for chronic joint infections

Biotech, Redwood City CA

Named, Executive Officer.

$6.093M

sold

Form D

Network

At Trellis Bioscience

4 people